Vera Therapeutics, Inc.
VERA
36 insider filings · Latest: Sep 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Feb 23 9:44 PM | LAURENCE SKELTON | Proposed Sale | 1,800 | $42.04 | $75.7K | — | View → |
| Feb 23, 2026 | Feb 23 9:42 PM | WILLIAM DONALD TURNER | Proposed Sale | 2,600 | $42.04 | $109.3K | — | View → |
| Feb 23, 2026 | Feb 23 9:41 PM | SEAN GRANT | Proposed Sale | 5,700 | $42.04 | $239.6K | — | View → |
| Feb 23, 2026 | Feb 23 9:39 PM | ROBERT BRENNER | Proposed Sale | 2,500 | $42.04 | $105.1K | — | View → |
| Feb 23, 2026 | Feb 23 9:31 PM | DAVID L JOHNSON | Proposed Sale | 2,900 | $42.04 | $121.9K | — | View → |
| Feb 23, 2026 | Feb 23 9:29 PM | MARSHALL FORDYCE | Proposed Sale | 16,600 | $42.04 | $697.8K | — | View → |
| Dec 15, 2025 | Dec 15 9:17 PM | WILLIAM TURNER | Proposed Sale | 10,000 | $49.80 | $498.0K | — | View → |
| Dec 8, 2025 | Dec 8 9:41 PM | WILLIAM TURNER | Proposed Sale | 10,000 | $44.90 | $449.0K | — | View → |
| Dec 3, 2025 | Dec 3 9:31 PM | WILLIAM TURNER | Proposed Sale | 10,000 | $37.25 | $372.5K | — | View → |
| Nov 21, 2025 | Nov 25 2:22 AM | Carter Jason S | Proposed Sale | 3,864 | $27.87 | $107.7K | — | View → |
| Feb 26, 2025 | Feb 26 9:21 PM | MARSHALL FORDYCE | Proposed Sale | 9,075 | $27.10 | $245.9K | — | View → |
| Jan 8, 2025 | Jan 8 9:22 PM | MARSHALL FORDYCE | Proposed Sale | 17,500 | $42.10 | $736.8K | — | View → |
| Dec 18, 2024 | Dec 18 9:24 PM | MARSHALL FORDYCE | Proposed Sale | 17,500 | $43.91 | $768.4K | — | View → |
| Dec 11, 2024 | Dec 11 9:59 PM | MARSHALL FORDYCE | Proposed Sale | 17,500 | $46.92 | $821.1K | — | View → |
| Nov 25, 2024 | Nov 25 9:40 PM | MARSHALL FORDYCE | Proposed Sale | 19,375 | $48.31 | $936.0K | — | View → |
| Nov 13, 2024 | Nov 13 9:23 PM | MARSHALL FORDYCE | Proposed Sale | 30,625 | $48.54 | $1.5M | — | View → |
| Oct 28, 2024 | Oct 28 8:37 PM | BETH C SEIDENBERG | Proposed Sale | 15,000 | $41.09 | $616.4K | — | View → |
| Oct 23, 2024 | Oct 23 8:16 PM | MARSHALL FORDYCE | Proposed Sale | 19,375 | $40.71 | $788.8K | — | View → |
| Oct 9, 2024 | Oct 9 8:17 PM | MARSHALL FORDYCE | Proposed Sale | 15,625 | $38.64 | $603.8K | — | View → |
| Sep 25, 2024 | Sep 25 8:21 PM | MARSHALL FORDYCE | Proposed Sale | 7,500 | $46.71 | $350.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Feb 7 1:00 AM | Sean GrantCHIEF FINANCIAL OFFICER | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | Laurence Matthew SkeltonChief Commercial Officer | Grant/Award | 40,000 | $42.74 | 40,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | William D. TurnerChief Regulatory Officer | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | David Lee JohnsonChief Operating Officer | Grant/Award | 40,000 | $42.74 | 40,000(D) | View → |
| Feb 4, 2026 | Feb 7 1:00 AM | Robert BrennerChief Medical Officer | Grant/Award | 50,000 | $42.74 | 50,000(D) | View → |
← Previous
Page 2 of 2